Modeling the risk of an emerging pathogen entering the Canadian blood supply

Transfusion

Volumn 50, Issue 12, 2010, Pages 2592-2606

  Kleinman, Steven ^a   Cameron, Claire ^a   Custer, Brian ^a   Busch, Michael ^a   Katz, Louis ^a   Kralj, Boris ^a   Matheson, Ian ^a   Murphy, Ken ^a   Preiksaitis, Jutta ^a   Devine, Dana ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; CANADA; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; INCIDENCE; INFECTION; INFECTION RATE; INFECTION RISK; MATHEMATICAL MODEL; MORBIDITY; PERSISTENT INFECTION; PREVALENCE; RECIPIENT; RISK ASSESSMENT; RISK MANAGEMENT; SECONDARY INFECTION; SEX; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTION; MALE; MIDDLE AGED; MODELS, THEORETICAL; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 78649983476     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02724.x     Document Type: Article

References (45)

1. Vamvakas S, Kleinman S, Hume H, Sher G,. The development of West Nile virus safety policies by Canadian Blood Services: guiding principles and a comparison between Canada and the United States of America. Transfus Med Rev 2006; 20: 97-109.
2. Turner ML, Ludlam CA,. An update on the assessment and management of the risk of transmission of variant Creutzfeldt disease by blood and plasma products. Br J Hematol 2009; 144: 14-23.
3. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA,. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009; 49: 2557-63.
4. Linnen JM, Vinelli E, Sabino EC, Tobler LH, Hyland C, Lee TH, Kolk DP, Broulik AS, Collins CS, Lanciotti RS, Busch MP,. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion 2008; 48: 1355-62.
5. Seed CR, Kiely P, Hyland CA, Keller AJ,. The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. Transfusion 2009; 49: 1482-7.
6. Brouard C, Bernillon P, Quatresous I, Pillonel J, Assal A, De Valk H, Desenclos JC,. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008; 48: 1333-41.
7. Shang G, Biggerstaff BJ, Yang B, Shao C, Farrugia A,. Theoretically estimated risk of severe acute respiratory syndrome transmission through blood transfusion during an epidemic in Shenzehen, Guangdong, China in 2003. Transfus Apher Sci 2007; 37: 233-40.
8. Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ,. Influenza viremia and the potential for blood-borne transmission. Transfusion 2007; 47: 1080-8.
9. Hourfar MK, Themann A, Eickmann M, Puthavathana P, Laue T, Seifried E, Schmidt M,. Blood screening for influenza. Emerg Infect Dis 2007; 13: 1081-3.
10. Gray C,. Long before Krever's report, blood scare had changed face of medicine. CMAJ 1998; 158: 89-91.
11. Capen K,. There's more to Krever's report than the blood issue-much more. CMAJ 1998; 158: 92-4.
12. Hoey J,. The sensibility of safety: reflections on the Krever inquiry's final report. CMAJ 1998; 158: 59-60.
13. Health Canada. Commission of inquiry on the blood system in Canada (Krever Commission). Ottawa: Health Canada. Available from: URL: http://www.hc-sc.gc.ca/ahcasc/activit/com/krever-eng.php
14. Kaplan HS, Kleinman S,. Serological tests for infection with human immunodeficiency virus. Lab Med 1986; 17: 690-3.
15. Kleinman SH, Lelie N, Busch MP,. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009; 49: 2454-89.
16. Biggerstaff BJ, Petersen LR,. Estimated risk of transmission of the West Nile virus in the US, 2002. Transfusion 2003; 43: 1007-17.
17. Liumbruno GM, Calteri D, Petropulacos K, Mattivi A, Po C, Macini P, Tomasini I, Zucchelli P, Silvestri AR, Sambri V, Pupella S, Catalano L, Piccinini V, Calizzani G, Grazzini G,. The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008; 6: 199-210.
18. Delwart EL,. Viral metagenomics. Rev Med Virol 2007; 17: 115-31.
19. Wang D, Coscoy L, Zylberberg M, Avila PC, Boushey HA, Ganem D, DeRisi JL,. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci USA 2002; 99: 15687-92.
20. Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, Conlan S, Quan PL, Hui J, Marshall J, Simons JF, Egholm M, Paddock CD, Shieh WJ, Goldsmith CS, Zaki SR, Catton M, Lipkin WI,. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008; 358: 991-8.
21. Kamper-Jorgensen M, Ahlgren M, Rostgaard K, Malbye M, Edgren G, Nyren O, Reilly M, Norda R, Titlestad K, Tynell E, Hjalgrim M,. Survival after blood transfusion. Transfusion 2008; 48: 2577-84.
22. Kleinman S, Marshall D, AuBuchon J, Patton M,. Survival after transfusion as assessed in a large multistate US cohort. Transfusion 2004; 44: 386-90.
23. Vamvakas EC, Goldstein R,. Four-year survival of transfusion recipients identified by hepatitis C lookback. Transfusion 2002; 42: 691-7.
24. Vamvakas EC,. Ten-year survival of transfusion recipients identified by hepatitis C lookback. Transfusion 2003; 43: 418-9.
25. Gauvin F, Champagne MA, Robillard P, Le Cruguel JP, Lapointe H, Hume H,. Long-term survival rate of pediatric patients after blood transfusion. Transfusion 2008; 48: 801-8.
26. Cobain TJ, Vamvakas EC, Wells A, Titlestad K,. A survey of the demographics of blood use. Transfus Med 2007; 17: 1-15.
27. Hahn JA,. Sex, drugs, and hepatitis C virus. J Infect Dis 2007; 195: 1556-9.
28. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD,. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr 1994; 7: 705-10.
29. Hogg RS, Heath K, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS,. Improved survival among HIV-infected individuals following initiation of antiviral therapy. JAMA 1998; 279: 450-4.
30. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD,. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-60.
31. Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, Montaner JS,. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568-77.
32. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, Costagliola D, D'Arminio Monforte A, De Wolf F, Reiss P, Lundgren JD, Justice AC, Staszewski S, Leport C, Hogg RS, Sabin CA, Gill MJ, Salzberger B, Sterne JA, ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-29. (Pubitemid 34786200)
33. Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, Drebot M, Neupane B, Fearon M, Mahony J,. Prognosis after West Nile virus infection. Ann Intern Med 2008; 149: 232-41.
34. Rao N, Char D, Gnatz S,. Rehabilitation outcomes of 5 patients with severe West Nile virus infection: a case series. Arch Phys Med Rehabil 2005; 86: 449-52.
35. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, Austin CC, Gerber SI,. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 2004; 141: 360-5.
36. Wallis JP, Wells AW, Matthews JN, Chapman CE,. Long-term survival after blood transfusion: a population based study in the North of England. Transfusion 2004; 44: 1025-32.
37. Vamvakas EC, Taswell HF,. Long-term survival after blood transfusion. Transfusion 1994; 34: 471-7.
38. Biggerstaff BJ, Petersen LR,. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-26.
39. Mohammed H, Linnen JM, Munoz-Jordan JL, Tomashek K, Foster G, Broulik A, Petersen L, Stramer SL,. Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008; 48: 1348-54.
40. Wilder-Smith A, Chen LH, Massad E, Wilson ME,. Threat of Dengue to blood safety in Dengue-endemic countries. Emerging Infectious Diseases 2009; 15: 8-11.
41. Welch J, Maclaren K, Jordan T, Simmond P,. Frequency, viral loads, and serotype identification of enterovirus infections in Scottish blood donors. Transfusion 2003; 43: 1060-6.
42. Williams AE, Fang CT, Slamon DJ, Poiesz BJ, Sandler SG, Darr WF 2nd, Shulman G, McGowan EI, Douglas DK, Bowman RJ,. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988; 240: 643-6.
43. Donahue JG, Munoz A, Ness PM, Briwn DE Jr, Yawn DH, McAlister HA, Reitz BA, Nelson KE,. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-73.
44. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, Le Grice M, Ritchie DL, McCardle LM, Hilton DA,. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 2006; 332: 1186-8.
45. Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ,. Possible transmission of human herpesvirus 8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45: 500-3.